Status: Recruiting
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment. The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.
Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Ray Therapeutics, Inc.Updated: Jan 8, 2025Locations: 1
Eligibility criteria
Diagnosis of bilateral retinitis pigmentosa, choroideremia, Stargardt macular dy... [+2]
Cognitive impairment, memory loss or dementia sufficient in severity to preclude... [+2]